Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry-Reference-Cited by-同舟云学术

Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry

Published:2011-10-20 Issue:3 Volume:131 Page:558-569
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Laerum Ole Didrik,Ovrebo Kjell,Skarstein Arne,Christensen Ib Jarle,Alpízar-Alpízar Warner,Helgeland Lars,Danø Keld,Nielsen Boye Schnack,Illemann Martin

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Epidemiology and biology of esophageal cancer;Demeester;Gastrointest Cancer Res,2009

2. The molecular mechanisms of oesophageal cancer;McCabe;Int Immunopharmacol,2005

3. Barrett's esophagus: diagnostic challenges and recent developments;Maru;Ann Diagn Pathol,2009

4. Mechanisms of disease: carcinogenesis in Barrett's esophagus;Buttar;Nat Clin Pract Gastroenterol Hepatol,2004

5. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies;Folgueras;Int J Dev Biol,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts;Current Radiopharmaceuticals;2021-11-10

2. The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities;Cancers;2021-10-27

3. The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer;Cancers;2021-10-12

4. Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma;Cancers;2021-08-14

5. Fluorescence guided intraluminal endoscopy in the gastrointestinal tract: A systematic review;World Journal of Gastrointestinal Endoscopy;2020-10-16